Fundraising Fox

Lytica Therapeutics

Cambridge, US · Founded 2019 · Delaware corporation

Biotech

Founders & leadership

RM
RIDA MOURTADANamed on SEC filing

Board

JL
JAMES LATORREBoard director
DM
DANIEL MACAYABoard director
JD
JEAN-FRANCOIS DUCRESTBoard director

Reported raises · per SEC filings

Form D private placements

$11.8M disclosed across 3 rounds · 2024–2025

▶$6MraisedApr 2025 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JEAN-FRANCOIS DUCRESTDirector
  • JAMES LATORREDirector
  • DANIEL MACAYADirector
  • RIDA MOURTADAExecutive Officer, Director
Amount sold
$6M
First sale
Feb 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.8MraisedAug 2024 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JAMES LATORREDirector
  • DANIEL MACAYADirector
  • RIDA MOURTADAExecutive Officer, Director
  • JEAN-FRANCOIS DUCRESTDirector
Amount sold
$1.8M
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.1MraisedMar 2024 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JEAN-FRANCOIS DUCRESTDirector
  • DANIEL MACAYADirector
  • RIDA MOURTADAExecutive Officer, Director
  • JAMES LATORREExecutive Officer, Director
Amount sold
$4.1M
First sale
Feb 2024
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Top 10 Oncology Capital Raises in the U.S. - April 1st-15th, 2025castleplacement.com · Apr 2025Lytica Therapeutics has filed a notice of an exempt offering of securities to raise $6 Million in New Debt Financing. - intelligence360intelligence360.news · Apr 2025CARB-X funds Lytica Therapeutics to develop antibacterial peptides to treat drug-resistant infections in the lungs and other parts of the body - Carb-Xcarb-x.org · Feb 2020Lytica Snags CARB-X Funding for Antibacterial Peptide Research - BioSpacebiospace.com · Feb 2020

Frequently asked questions

How much funding has Lytica Therapeutics raised?
Lytica Therapeutics has disclosed $11.8M raised across 3 rounds.
Where is Lytica Therapeutics headquartered?
Lytica Therapeutics is headquartered in Cambridge, US.